The Claim
Cytochrome P450 1B1 is highly upregulated in the colon during colitis in both mice and humans, and its presence is associated with increased severity of inflammatory bowel disease and colitis-associated colorectal cancer through a mechanism involving pathogenic Th17 cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people and mice with colitis, the enzyme Cytochrome P450 1B1 is present at higher levels in the colon, and this increase is linked to more severe inflammatory bowel disease and a higher risk of colorectal cancer through the activity of pathogenic Th17 cells.
See the scientific wording
Cytochrome P450 1B1 is highly upregulated in the colon during colitis in both mice and humans, and its presence is associated with increased severity of inflammatory bowel disease and colitis-associated colorectal cancer through a mechanism involving pathogenic Th17 cells.
In inflamed colon tissue, a protein called CYP1B1 increases and causes harmful immune cells to accumulate reactive oxygen species, which damages their energy-producing mitochondria. This damage prevents the immune cells from dying properly and makes them more aggressive, leading to worse inflammation and tumor growth in the colon.
What the research says
1 studyIn people and mice with inflamed colons, a protein called CYP1B1 gets turned up high, and this makes harmful immune cells (Th17) even worse, leading to more inflammation and higher cancer risk. The study shows exactly how this happens inside the cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.